Welcome to our dedicated page for Ivy Funds - Delaware Ivy High Income Opportunities Fund news (Ticker: IVH), a resource for investors and traders seeking the latest updates and insights on Ivy Funds - Delaware Ivy High Income Opportunities Fund stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ivy Funds - Delaware Ivy High Income Opportunities Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ivy Funds - Delaware Ivy High Income Opportunities Fund's position in the market.
Ivy High Income Opportunities Fund (NYSE: IVH) held Special Shareholder Meetings on April 1, 2021, where shareholders approved several key proposals. These include the election of new trustees for various classes, the establishment of a new investment advisory agreement for the Fund, and the approval of sub-advisory agreements with Macquarie Investment Management entities. The Fund aims to provide total return through high yield corporate bonds and other fixed income instruments, though investments may involve higher risks, including trading at a discount from net asset values.
FAQ
What is the market cap of Ivy Funds - Delaware Ivy High Income Opportunities Fund (IVH)?
